New CBD (Cannabidiol) Product Could Have Devastating Health Consequences

Curtis Howell PURE CBD Leave a Comment

At the beginning of this year, Stevia Corp filed a provisional patent for a product that would combine acetaminophen with cannabidiol (CBD) to treat pain. A provisional patent is set to automatically expire at the end of one year, and can be regarded as the preliminary stages of a patent, hence the popular marketing term, “patent pending” – what this means, however, is come January of 2016, Stevia Corp must file for a non-provisional patent so that the United States Patent and Trademark Office (USPTO) can officially examine the patent for approval or rejection. If the USPTO grants the patent, a potentially dangerous combination may soon flood the CBD industry.

While CBD itself poses absolutely no proven health risks aside from manufacturer error (a problem which can be virtually eliminated by using CBD isolate), acetaminophen has been recognized by the FDA as “a serious public health problem” for over ten years due to its high rates of liver failure. In fact, a study from the Center for Disease Control and Prevention (CDC) found that the over-the-counter medicine was the leading cause of liver failure in the United States from 1998 to 2003. A follow-up study in 2007 confirmed that acetaminophen was once again the leading cause of acute liver failure, even more so than alcohol.

overdose-acetaminophenAs if this weren’t enough, results show that it is easy to accidentally overdose on acetaminophen as well. Of all the acetaminophen overdoses in the study from 1998 to 2003, nearly half were unintentional. The FDA itself admits that “some individuals may be especially prone to liver injury from acetaminophen”, and that even “taking just a small amount more than the recommended daily dose of acetaminophen” can cause liver damage.

It is impossible to overdose on CBD.


In addition, acetaminophen is known to be contraindicative with a wide variety of other well-known pain-relieving medicines, such as Motrin and Naproxen, and at least one type of blood pressure medication. Likewise, people who are pregnant, nursing, have a liver disease, or drink at last once a day should also refrain from ever using acetaminophen.

The question is, why would Stevia Corp seek to mix a drug that the FDA describes as having “only a small difference between the maximum daily dose and a potentially harmful dose”? Some speculate that it proves the legitimate threat that CBD poses to the pharmaceutical industry as a whole. The infusion of acetaminophen and CBD could be seen as market equivalent of the age-old proverb, “if you can’t beat them, join them.”

Whatever the reason may be, Stevia Corp reported a 12% increase in shares after announcing the provisional patent. However, it would only conceivably take one fatal acetaminophen overdose to set the company back considerably, which science shows may be very likely. For the full story, click here.

What do you think of this issue? We want to hear your comments! Please comment below!

Visit our blog at CBD PUR US for more news, information, and interesting facts about Cannabidiol (CBD).

Leave a Reply